Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy

Elena H. Chartoff, Mark S. Szczypka, Richard D. Palmiter, Daniel Dorsa

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The neuropeptide neurotensin (NT) is highly sensitive to changes in dopaminergic signaling in the striatum, and is thought to modulate dopamine-mediated behaviors. To explore the interaction of NT with the dopamine system, we utilized mice with a targeted deletion of dopamine synthesis specifically in dopaminergic neurons. Dopamine levels in dopamine-deficient (DD) mice are less than 1% of control mice, and they require daily administration of the dopamine precursor l-dihydroxyphenylalanine (l-DOPA) for survival. DD mice are supersensitive to the effects of dopamine, becoming hyperactive relative to control mice in the presence of l-DOPA. We show that 24 h after l-DOPA treatment, when DD mice are in a "dopamine-depleted" state, Nt mRNA levels in the striatum of DD mice are similar to those in control mice. Administration of l-DOPA or l-DOPA plus the l-amino acid decarboxylase inhibitor, carbidopa, (C/l-DOPA) induced Nt expression in the striatum of DD mice. The dopamine D1 receptor antagonist, SCH23390, blocked C/l-DOPA-induced Nt. To test the hypothesis that this striatal Nt expression modulated dopamine-mediated behavior in DD mice, we administered SR 48692, an antagonist of the high affinity NT receptor, together with l-DOPA or C/l-DOPA. l-DOPA-induced hyperlocomotion and C/l-DOPA-induced stereotypy were potentiated by peripheral administration of SR 48692. Furthermore, intrastriatal microinjections of SR 48692 augmented l-DOPA-induced hyperlocomotion. These results demonstrate a dynamic regulation of striatal Nt expression by dopamine via D1 receptors in DD mice, and point to a physiological role for endogenous striatal NT in counteracting motor behaviors induced by an overactive dopamine system.

Original languageEnglish (US)
Pages (from-to)71-80
Number of pages10
JournalBrain Research
Volume1022
Issue number1-2
DOIs
StatePublished - Oct 1 2004

Fingerprint

Neurotensin
Locomotion
Dihydroxyphenylalanine
Dopamine
Corpus Striatum
Dopamine D1 Receptors
Neurotensin Receptors
Carbidopa
Carboxy-Lyases
Dopamine Antagonists
Dopaminergic Neurons
Microinjections
Neuropeptides

Keywords

  • Dopamine-deficient mouse
  • l-DOPA
  • Microinjection
  • Neuropeptide
  • SR 48692
  • Striatum

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy. / Chartoff, Elena H.; Szczypka, Mark S.; Palmiter, Richard D.; Dorsa, Daniel.

In: Brain Research, Vol. 1022, No. 1-2, 01.10.2004, p. 71-80.

Research output: Contribution to journalArticle

Chartoff, Elena H. ; Szczypka, Mark S. ; Palmiter, Richard D. ; Dorsa, Daniel. / Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy. In: Brain Research. 2004 ; Vol. 1022, No. 1-2. pp. 71-80.
@article{b637c8a4c20b4b63bba3d27b33df5ea7,
title = "Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy",
abstract = "The neuropeptide neurotensin (NT) is highly sensitive to changes in dopaminergic signaling in the striatum, and is thought to modulate dopamine-mediated behaviors. To explore the interaction of NT with the dopamine system, we utilized mice with a targeted deletion of dopamine synthesis specifically in dopaminergic neurons. Dopamine levels in dopamine-deficient (DD) mice are less than 1{\%} of control mice, and they require daily administration of the dopamine precursor l-dihydroxyphenylalanine (l-DOPA) for survival. DD mice are supersensitive to the effects of dopamine, becoming hyperactive relative to control mice in the presence of l-DOPA. We show that 24 h after l-DOPA treatment, when DD mice are in a {"}dopamine-depleted{"} state, Nt mRNA levels in the striatum of DD mice are similar to those in control mice. Administration of l-DOPA or l-DOPA plus the l-amino acid decarboxylase inhibitor, carbidopa, (C/l-DOPA) induced Nt expression in the striatum of DD mice. The dopamine D1 receptor antagonist, SCH23390, blocked C/l-DOPA-induced Nt. To test the hypothesis that this striatal Nt expression modulated dopamine-mediated behavior in DD mice, we administered SR 48692, an antagonist of the high affinity NT receptor, together with l-DOPA or C/l-DOPA. l-DOPA-induced hyperlocomotion and C/l-DOPA-induced stereotypy were potentiated by peripheral administration of SR 48692. Furthermore, intrastriatal microinjections of SR 48692 augmented l-DOPA-induced hyperlocomotion. These results demonstrate a dynamic regulation of striatal Nt expression by dopamine via D1 receptors in DD mice, and point to a physiological role for endogenous striatal NT in counteracting motor behaviors induced by an overactive dopamine system.",
keywords = "Dopamine-deficient mouse, l-DOPA, Microinjection, Neuropeptide, SR 48692, Striatum",
author = "Chartoff, {Elena H.} and Szczypka, {Mark S.} and Palmiter, {Richard D.} and Daniel Dorsa",
year = "2004",
month = "10",
day = "1",
doi = "10.1016/j.brainres.2004.06.061",
language = "English (US)",
volume = "1022",
pages = "71--80",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy

AU - Chartoff, Elena H.

AU - Szczypka, Mark S.

AU - Palmiter, Richard D.

AU - Dorsa, Daniel

PY - 2004/10/1

Y1 - 2004/10/1

N2 - The neuropeptide neurotensin (NT) is highly sensitive to changes in dopaminergic signaling in the striatum, and is thought to modulate dopamine-mediated behaviors. To explore the interaction of NT with the dopamine system, we utilized mice with a targeted deletion of dopamine synthesis specifically in dopaminergic neurons. Dopamine levels in dopamine-deficient (DD) mice are less than 1% of control mice, and they require daily administration of the dopamine precursor l-dihydroxyphenylalanine (l-DOPA) for survival. DD mice are supersensitive to the effects of dopamine, becoming hyperactive relative to control mice in the presence of l-DOPA. We show that 24 h after l-DOPA treatment, when DD mice are in a "dopamine-depleted" state, Nt mRNA levels in the striatum of DD mice are similar to those in control mice. Administration of l-DOPA or l-DOPA plus the l-amino acid decarboxylase inhibitor, carbidopa, (C/l-DOPA) induced Nt expression in the striatum of DD mice. The dopamine D1 receptor antagonist, SCH23390, blocked C/l-DOPA-induced Nt. To test the hypothesis that this striatal Nt expression modulated dopamine-mediated behavior in DD mice, we administered SR 48692, an antagonist of the high affinity NT receptor, together with l-DOPA or C/l-DOPA. l-DOPA-induced hyperlocomotion and C/l-DOPA-induced stereotypy were potentiated by peripheral administration of SR 48692. Furthermore, intrastriatal microinjections of SR 48692 augmented l-DOPA-induced hyperlocomotion. These results demonstrate a dynamic regulation of striatal Nt expression by dopamine via D1 receptors in DD mice, and point to a physiological role for endogenous striatal NT in counteracting motor behaviors induced by an overactive dopamine system.

AB - The neuropeptide neurotensin (NT) is highly sensitive to changes in dopaminergic signaling in the striatum, and is thought to modulate dopamine-mediated behaviors. To explore the interaction of NT with the dopamine system, we utilized mice with a targeted deletion of dopamine synthesis specifically in dopaminergic neurons. Dopamine levels in dopamine-deficient (DD) mice are less than 1% of control mice, and they require daily administration of the dopamine precursor l-dihydroxyphenylalanine (l-DOPA) for survival. DD mice are supersensitive to the effects of dopamine, becoming hyperactive relative to control mice in the presence of l-DOPA. We show that 24 h after l-DOPA treatment, when DD mice are in a "dopamine-depleted" state, Nt mRNA levels in the striatum of DD mice are similar to those in control mice. Administration of l-DOPA or l-DOPA plus the l-amino acid decarboxylase inhibitor, carbidopa, (C/l-DOPA) induced Nt expression in the striatum of DD mice. The dopamine D1 receptor antagonist, SCH23390, blocked C/l-DOPA-induced Nt. To test the hypothesis that this striatal Nt expression modulated dopamine-mediated behavior in DD mice, we administered SR 48692, an antagonist of the high affinity NT receptor, together with l-DOPA or C/l-DOPA. l-DOPA-induced hyperlocomotion and C/l-DOPA-induced stereotypy were potentiated by peripheral administration of SR 48692. Furthermore, intrastriatal microinjections of SR 48692 augmented l-DOPA-induced hyperlocomotion. These results demonstrate a dynamic regulation of striatal Nt expression by dopamine via D1 receptors in DD mice, and point to a physiological role for endogenous striatal NT in counteracting motor behaviors induced by an overactive dopamine system.

KW - Dopamine-deficient mouse

KW - l-DOPA

KW - Microinjection

KW - Neuropeptide

KW - SR 48692

KW - Striatum

UR - http://www.scopus.com/inward/record.url?scp=4444373758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444373758&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2004.06.061

DO - 10.1016/j.brainres.2004.06.061

M3 - Article

C2 - 15353215

AN - SCOPUS:4444373758

VL - 1022

SP - 71

EP - 80

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -